ResearcherSecond Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical UniversityNo recent work listed

Yun He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0377-5851; OpenAlex author ID A5101876620. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper

Papers 2

High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer. Co-author DOI 10.3892/ijo.2016.3828 ↗
Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2015.4353 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhanxiong Xue · 2 shared papers, 2016–2017 · strength 0.12
- Paper High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer. DOI 10.3892/ijo.2016.3828 ↗
- Paper Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2015.4353 ↗
Zhenzhai Cai · 2 shared papers, 2016–2017 · strength 0.12
- Paper High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer. DOI 10.3892/ijo.2016.3828 ↗
- Paper Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2015.4353 ↗
Yunfeng Shan · 2 shared papers, 2016–2017 · strength 0.12
- Paper High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer. DOI 10.3892/ijo.2016.3828 ↗
- Paper Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. DOI 10.3892/or.2015.4353 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.